A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

La Jolla Pharmaceuticals

About La Jolla Pharmaceuticals

La Jolla Pharmaceutical Company is a biotechnology company leading the development of therapeutics for antibody-mediated autoimmune diseases afflicting several million people in the United States and Europe. The Company is developing Riquent® (abetimus sodium) for the treatment of patients with lupus kidney disease, a leading cause of sickness and death in lupus patients.

The Company is also developing LJP 1082, for the treatment of antibody-mediated thrombosis, a condition in which patients can suffer from recurrent stroke, deep-vein thrombosis, and other thrombotic events. The Company is developing highly selective inhibitors of semicarbazide-sensitive amine oxidase (SSAO), an enzyme that has been implicated in inflammatory responses in many tissues and organs.


Clinical Trials for La Jolla


Toleragens®-- inactivating targeted B cells


More on La Jolla

Home Page

Key Statistics for La Jolla

Basic Chart for La Jolla

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.